<VariationArchive RecordType="classified" VariationID="16459" VariationName="NM_000138.5(FBN1):c.5074_5097del (p.Arg1692_Tyr1699del)" VariationType="Deletion" Accession="VCV000016459" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-11-05" DateCreated="2016-10-02" MostRecentSubmission="2016-10-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31498" VariationID="16459">
      <GeneList>
        <Gene Symbol="FBN1" FullName="fibrillin 1" GeneID="2200" HGNC_ID="HGNC:3603" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48408313" stop="48645709" display_start="48408313" display_stop="48645709" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48700502" stop="48937984" display_start="48700502" display_stop="48937984" Strand="-" />
          </Location>
          <OMIM>134797</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000138.5(FBN1):c.5074_5097del (p.Arg1692_Tyr1699del)</Name>
      <CanonicalSPDI>NC_000015.10:48463208:GTAGTTTCTGTAGCACAAACTTCT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48463209" stop="48463232" display_start="48463209" display_stop="48463232" variantLength="24" positionVCF="48463208" referenceAlleleVCF="AGTAGTTTCTGTAGCACAAACTTCT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48755406" stop="48755429" display_start="48755406" display_stop="48755429" variantLength="24" positionVCF="48755405" referenceAlleleVCF="AGTAGTTTCTGTAGCACAAACTTCT" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_778" sequenceAccession="LRG_778">
            <Expression>LRG_778:g.187557_187580del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_778t1" sequenceAccession="LRG_778t1">
            <Expression>LRG_778t1:c.5074_5097del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_778p1" sequenceAccession="LRG_778p1" change="p.Arg1692_Tyr1699del">
            <Expression>LRG_778p1:p.Arg1692_Tyr1699del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.48463209_48463232del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.48463209_48463232del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.48755406_48755429del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.48755406_48755429del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008805.2" sequenceAccession="NG_008805" sequenceVersion="2" change="g.187557_187580del">
            <Expression>NG_008805.2:g.187557_187580del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000138.5" sequenceAccession="NM_000138" sequenceVersion="5" change="c.5074_5097del" MANESelect="true">
            <Expression>NM_000138.5:c.5074_5097del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000129.3" sequenceAccession="NP_000129" sequenceVersion="3" change="p.Arg1692_Tyr1699del">
            <Expression>NP_000129.3:p.Arg1692_Tyr1699del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645373007" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="134797.0040" DB="OMIM" />
        <XRef Type="rs" ID="1555396783" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000138.5(FBN1):c.5074_5097del (p.Arg1692_Tyr1699del) AND Weill-Marchesani syndrome 2, dominant" Accession="RCV000017922" Version="28">
        <ClassifiedConditionList TraitSetID="5411">
          <ClassifiedCondition DB="MedGen" ID="C1869115">Weill-Marchesani syndrome 2, dominant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-02" MostRecentSubmission="2016-10-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12525539</ID>
        </Citation>
        <Citation Type="general">
          <CitationText>Gorlin, R. J., L'Heureux, R. R., Shapiro, I. Weill-Marchesani syndrome in two generations: genetic heterogeneity or pseudodominance? J. Pediat. Ophthal. 11: 139-144, 1974.</CitationText>
        </Citation>
        <ConditionList>
          <TraitSet ID="5411" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5118" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Weill-Marchesani syndrome 2</ElementValue>
                <XRef ID="Weill-Marchesani+syndrome+2/9473" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glaucoma, Ectopia, Microspherophakia, Stiff joints and Short stature syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Weill-Marchesani Syndrome, Autosomal Dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Weill-Marchesani syndrome 2, dominant</ElementValue>
                <XRef ID="MONDO:0012013" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WMS2</ElementValue>
                <XRef Type="MIM" ID="608328" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GEMSS</ElementValue>
                <XRef Type="MIM" ID="608328" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Weill-Marchesani syndrome (WMS) is a connective tissue disorder characterized by abnormalities of the lens of the eye, short stature, brachydactyly, joint stiffness, and cardiovascular defects. The ocular problems, typically recognized in childhood, include microspherophakia (small spherical lens), myopia secondary to the abnormal shape of the lens, ectopia lentis (abnormal position of the lens), and glaucoma, which can lead to blindness. Height of adult males is 142-169 cm; height of adult females is 130-157 cm. Autosomal recessive WMS cannot be distinguished from autosomal dominant WMS by clinical findings alone.</Attribute>
                <XRef ID="NBK1114" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL</Attribute>
                <XRef Type="MIM" ID="608328" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2452" />
                <XRef ID="2452" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301293</ID>
                <ID Source="BookShelf">NBK1114</ID>
              </Citation>
              <XRef ID="2084" DB="Orphanet" />
              <XRef ID="C1869115" DB="MedGen" />
              <XRef ID="MONDO:0012013" DB="MONDO" />
              <XRef Type="MIM" ID="608328" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38201" SubmissionDate="2016-09-28" DateLastUpdated="2016-10-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134797.0040_WEILL-MARCHESANI SYNDROME 2" title="FBN1, 24-BP DEL_WEILL-MARCHESANI SYNDROME 2" />
        <ClinVarAccession Accession="SCV000038201" DateUpdated="2016-10-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with autosomal dominant Weill-Marchesani syndrome (WMS2; 608328) first reported by Gorlin et al. (1974), Faivre et al. (2003) identified heterozygosity for a 24-bp in-frame deletion (5074del24) in exon 41 of the FBN1 gene. The mutation cosegregated with disease and was not found in 186 controls.</Attribute>
              <Citation>
                <CitationText>Gorlin, R. J., L'Heureux, R. R., Shapiro, I. Weill-Marchesani syndrome in two generations: genetic heterogeneity or pseudodominance? J. Pediat. Ophthal. 11: 139-144, 1974.</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">12525539</ID>
              </Citation>
              <XRef DB="OMIM" ID="608328" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBN1" />
          </GeneList>
          <Name>FBN1, 24-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">24-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134797.0040" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WEILL-MARCHESANI SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38201" TraitType="Disease" MappingType="Name" MappingValue="WEILL-MARCHESANI SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C1869115" Name="Weill-Marchesani syndrome 2, dominant" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

